Type 2 Diabetes: The Pathologic Basis of Reversible ß-Cell Dysfunction. (2016)

First Author: White MG
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/dc16-0619

PubMed Identifier: 27926891

Publication URI: http://europepmc.org/abstract/MED/27926891

Type: Journal Article/Review

Volume: 39

Parent Publication: Diabetes care

Issue: 11

ISSN: 0149-5992